Breaking News on Supplements & Nutrition - North AmericaEU edition
Outsourcing
Research, analytical testing, and manufacturing - all can be outsourced. But what are the drivers, and where are the challenges? In this four part special edition, NutraIngredients-USA.com looks at how to select a contract manufacturing, why GMPs are boosting contract analytical labs, and how CROs ensure success with clinical trials.
Clinical trial success: Design and recruitment
Designing a clinical trial correctly from the beginning is the most important issue for success, while a ready supply of volunteers for natural product clinical trials takes the pressure off patient recruitment, says the CEO of a CRO.
GMPs boosting need for contract analytical prowess
The introduction of good manufacturing practices (GMPs) is a boon for contract analytical services, and those with special services to offer are standing out from the crowd.
CROs (slowly) piece together EFSA's health claim science puzzle
In the second part of this special series on global outsourcing trends NutraIngredients explores how the European Union nutrition and health claims regulation (NHCR) is impacting activity in the contract research organisation (CRO) sector.
The challenge of choosing the right contract manufacturer
Brand owners may be obliged to work with contract manufacturers, but finding the right one can be no easy task. In the first part of our outsourcing special edition, Jules Birch of Works with Water Nutraceuticals explains the challenges – and the implications of getting it wrong.
Spotlight
  Vitamin Shoppe: US supplement user confidence soars to 93% as usage increasesTaking dietary supplements can boost confidence about health, according to The Vitamin Shoppe's annual survey, with usage... |
 NBTY: ‘DMAA-containing products represent less than 0.5% of our sales’The FDA crackdown on stimulant DMAA will not have a big impact on supplements giant NBTY, said... |
 Dispatches from AHPA's Botanical CongressFDA: We’re not enforcing NDI draft guidance; GMPs are the biggest issueThe Food & Drug Administration is not preparing to enforce its controversial draft guidance on new dietary... |
 Vitamin Shoppe boss quizzed on DMAA on Q1 earnings callVitamin Shoppe boss Tony Truesdale would not say how much the FDA crackdown on DMAA is likely... |